Major histocompatibility complex Class II-based therapy for stroke.

Gonzales-Portillo, Bella M; Lee, Jea-Young; Vandenbark, Arthur A; Offner, Halina; Borlongan, Cesario V

Gonzales-Portillo, Bella M; Lee, Jea-Young; Vandenbark, Arthur A; Offner, Halina; Borlongan, Cesario V.

Afiliação

Gonzales-Portillo BM; Department of Biomedical Engineering, Northwestern University, Evanston, IL, USA.
Lee JY; Department of Neurosurgery and Brain Repair, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
Vandenbark AA; Department of Veterans Affairs, Veterans Affairs Portland Health Care System, Portland, OR, USA.
Offner H; Department of Neurology, Oregon Health and Science University, Portland, OR, USA.
Borlongan CV; Department of Molecular Microbiology and Immunology and Anaesthesiology and Perioperative Medicine, Oregon Health and Science University, Portland, OR, USA.

Brain Circ ; 7(1): 37-40, 2021.

Article em En | MEDLINE | ID: mdl-34084976

Palavras-chave

Cell death; DRmQ; cytokines; mesenchymal stem cell; mitochondrial transfer; stem cell therapy; stroke therapy

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 6_cerebrovascular_disease Idioma: En Revista: Brain Circ Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google